Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.

Neuro-oncology·2026

Same author

A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.

Nature genetics·2026

Same author

Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes.

Neuro-oncology·2025

Same author

Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics.

Nature communications·2025

Same author

European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection.

Neuro-oncology·2024

Same author

Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype.

Genes & development·2024

Search research articles

相关实验视频

Updated: Jul 23, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

脑膜瘤的免疫疗法

Hans-Georg Wirsching¹, Michael Weller²

¹Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.

Advances in experimental medicine and biology

|July 11, 2023

概括

此摘要是机器生成的。

系统性免疫疗法为抗标准治疗的脑膜瘤患者提供了新的希望. 像免疫检查点抑制剂和癌症疫苗这样的新兴策略显示出控制复发性或晚期脑膜瘤的前景.

关键词:

收养T细胞疗法收养T细胞疗法两种方式的BiTE BiTE 免疫检查站检查站免疫结合体免疫结合体巨细胞是一个巨细胞.经常出现的脑膜瘤疫苗接种疫苗接种病毒疗法病毒疗法

更多相关视频

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关实验视频

Last Updated: Jul 23, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症治疗癌症治疗

背景情况:

脑膜瘤是主要的大脑瘤,在某些患者中,手术和放射治疗等局部治疗方法不足.
目前的全身疗法,包括化疗和抗血管原体药物,在晚期或复发性脑膜瘤中有效性有限.
免疫检查点抑制剂在其他晚期癌症中的成功表明免疫疗法在脑膜瘤治疗中的潜力.

研究的目的:

审查癌症免疫治疗的原则.
要总结目前的临床试验涉及免疫疗法为脑膜瘤患者.
讨论针对阴道瘤的既定和新型免疫治疗策略的潜在应用.

主要方法:

关于癌症免疫治疗原则的科学文献的综述.
对正在进行的脑膜瘤免疫治疗临床试验的分析.
讨论各种免疫疗法模式,包括免疫检查点抑制剂,疫苗,细胞疗法,T细胞参与剂和型病毒疗法.

主要成果:

经典化疗和抗血管原性疗法在脑膜瘤中表现出最小的活性.
免疫检查点抑制剂已经在其他转移性癌症中证明了长期生存益处.
广泛的免疫治疗方法正在研究或在临床上用于各种癌症.

结论:

系统性免疫疗法对那些对局部疗法没有反应的脑膜瘤患者来说是一个有希望的途径.
目前正在探索各种免疫疗法策略,包括新型免疫检查点抑制剂和治疗疫苗,用于脑膜瘤.
需要进一步的研究和临床试验,以确定这些免疫治疗方法在脑膜瘤管理中的有效性和适用性.